Colchicine treatment can be discontinued in a selected group of pediatric FMF patients

[1]  Y. Berkun,et al.  Discontinuation of Colchicine Therapy in Children With Familial Mediterranean Fever , 2021, The Journal of Rheumatology.

[2]  O. Barel,et al.  Clinical significance of E148Q heterozygous variant in paediatric Familial Mediterranean Fever. , 2021, Rheumatology.

[3]  H. E. Sönmez,et al.  Short-term follow-up results of children with familial Mediterranean fever after cessation of colchicine: is it possible to quit? , 2019, Rheumatology.

[4]  S. Özen,et al.  Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants , 2017, Clinical Rheumatology.

[5]  D. Kastner,et al.  EULAR recommendations for the management of familial Mediterranean fever , 2016, Annals of the rheumatic diseases.

[6]  I. Ben-Zvi,et al.  Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study , 2014, Orphanet Journal of Rare Diseases.

[7]  M. Ehrenfeld,et al.  Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. , 1999, American journal of medical genetics.

[8]  E. Ben-Chetrit,et al.  Colchicine: 1998 update. , 1998, Seminars in arthritis and rheumatism.

[9]  D. Zemer,et al.  Criteria for the diagnosis of familial Mediterranean fever. , 1997, Arthritis and rheumatism.

[10]  D. Zemer,et al.  Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. , 1986, The New England journal of medicine.

[11]  E. Sohar,et al.  The role of amyloidosis in familial mediterranean fever. A population study. , 1968, Israel journal of medical sciences.